Report Detail

This report focuses on the global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck&Co.
Medtronic
Sanofi-Aventis SA

Market segment by Type, the product can be split into
CLIA Method
ELISA Method
Market segment by Application, split into
Screening
Post-treatment Monitoring
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players.
To present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prostate-specific Antigen (PSA) Testing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Prostate-specific Antigen (PSA) Testing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Prostate-specific Antigen (PSA) Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 CLIA Method
    • 1.4.3 ELISA Method
  • 1.5 Market by Application
    • 1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Screening
    • 1.5.3 Post-treatment Monitoring
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Prostate-specific Antigen (PSA) Testing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Prostate-specific Antigen (PSA) Testing Industry
      • 1.6.1.1 Prostate-specific Antigen (PSA) Testing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Prostate-specific Antigen (PSA) Testing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Prostate-specific Antigen (PSA) Testing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Prostate-specific Antigen (PSA) Testing Market Perspective (2015-2026)
  • 2.2 Prostate-specific Antigen (PSA) Testing Growth Trends by Regions
    • 2.2.1 Prostate-specific Antigen (PSA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate-specific Antigen (PSA) Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Prostate-specific Antigen (PSA) Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Prostate-specific Antigen (PSA) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Market Size
    • 3.1.1 Global Top Prostate-specific Antigen (PSA) Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio
    • 3.2.1 Global Prostate-specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Prostate-specific Antigen (PSA) Testing Revenue in 2019
  • 3.3 Prostate-specific Antigen (PSA) Testing Key Players Head office and Area Served
  • 3.4 Key Players Prostate-specific Antigen (PSA) Testing Product Solution and Service
  • 3.5 Date of Enter into Prostate-specific Antigen (PSA) Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Prostate-specific Antigen (PSA) Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Type (2021-2026)

5 Prostate-specific Antigen (PSA) Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)
  • 5.2 Global Prostate-specific Antigen (PSA) Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 6.2 Prostate-specific Antigen (PSA) Testing Key Players in North America (2019-2020)
  • 6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 6.4 North America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 7.2 Prostate-specific Antigen (PSA) Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 7.4 Europe Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 8.2 Prostate-specific Antigen (PSA) Testing Key Players in China (2019-2020)
  • 8.3 China Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 8.4 China Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 9.2 Prostate-specific Antigen (PSA) Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 9.4 Japan Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 10.2 Prostate-specific Antigen (PSA) Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 11.2 Prostate-specific Antigen (PSA) Testing Key Players in India (2019-2020)
  • 11.3 India Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 11.4 India Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Prostate-specific Antigen (PSA) Testing Market Size (2015-2020)
  • 12.2 Prostate-specific Antigen (PSA) Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Prostate-specific Antigen (PSA) Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview and Its Total Revenue
    • 13.1.3 Abbott Prostate-specific Antigen (PSA) Testing Introduction
    • 13.1.4 Abbott Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020))
    • 13.1.5 Abbott Recent Development
  • 13.2 Boston Scientific Corporation
    • 13.2.1 Boston Scientific Corporation Company Details
    • 13.2.2 Boston Scientific Corporation Business Overview and Its Total Revenue
    • 13.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Introduction
    • 13.2.4 Boston Scientific Corporation Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.2.5 Boston Scientific Corporation Recent Development
  • 13.3 Bayer AG
    • 13.3.1 Bayer AG Company Details
    • 13.3.2 Bayer AG Business Overview and Its Total Revenue
    • 13.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Introduction
    • 13.3.4 Bayer AG Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.3.5 Bayer AG Recent Development
  • 13.4 Siemens Healthcare
    • 13.4.1 Siemens Healthcare Company Details
    • 13.4.2 Siemens Healthcare Business Overview and Its Total Revenue
    • 13.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Introduction
    • 13.4.4 Siemens Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.4.5 Siemens Healthcare Recent Development
  • 13.5 DiaSorin
    • 13.5.1 DiaSorin Company Details
    • 13.5.2 DiaSorin Business Overview and Its Total Revenue
    • 13.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Introduction
    • 13.5.4 DiaSorin Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.5.5 DiaSorin Recent Development
  • 13.6 Roche
    • 13.6.1 Roche Company Details
    • 13.6.2 Roche Business Overview and Its Total Revenue
    • 13.6.3 Roche Prostate-specific Antigen (PSA) Testing Introduction
    • 13.6.4 Roche Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.6.5 Roche Recent Development
  • 13.7 Beckman Coulter
    • 13.7.1 Beckman Coulter Company Details
    • 13.7.2 Beckman Coulter Business Overview and Its Total Revenue
    • 13.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Introduction
    • 13.7.4 Beckman Coulter Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.7.5 Beckman Coulter Recent Development
  • 13.8 PerkinElmer
    • 13.8.1 PerkinElmer Company Details
    • 13.8.2 PerkinElmer Business Overview and Its Total Revenue
    • 13.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Introduction
    • 13.8.4 PerkinElmer Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.8.5 PerkinElmer Recent Development
  • 13.9 Tosoh
    • 13.9.1 Tosoh Company Details
    • 13.9.2 Tosoh Business Overview and Its Total Revenue
    • 13.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Introduction
    • 13.9.4 Tosoh Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.9.5 Tosoh Recent Development
  • 13.10 Ortho Clinical
    • 13.10.1 Ortho Clinical Company Details
    • 13.10.2 Ortho Clinical Business Overview and Its Total Revenue
    • 13.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Introduction
    • 13.10.4 Ortho Clinical Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 13.10.5 Ortho Clinical Recent Development
  • 13.11 Fujirebio
    • 10.11.1 Fujirebio Company Details
    • 10.11.2 Fujirebio Business Overview and Its Total Revenue
    • 10.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Introduction
    • 10.11.4 Fujirebio Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.11.5 Fujirebio Recent Development
  • 13.12 Mediwatch
    • 10.12.1 Mediwatch Company Details
    • 10.12.2 Mediwatch Business Overview and Its Total Revenue
    • 10.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Introduction
    • 10.12.4 Mediwatch Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.12.5 Mediwatch Recent Development
  • 13.13 BodiTech
    • 10.13.1 BodiTech Company Details
    • 10.13.2 BodiTech Business Overview and Its Total Revenue
    • 10.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Introduction
    • 10.13.4 BodiTech Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.13.5 BodiTech Recent Development
  • 13.14 Bristol-Myers Squibb Company
    • 10.14.1 Bristol-Myers Squibb Company Company Details
    • 10.14.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
    • 10.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Introduction
    • 10.14.4 Bristol-Myers Squibb Company Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.14.5 Bristol-Myers Squibb Company Recent Development
  • 13.15 GE Healthcare
    • 10.15.1 GE Healthcare Company Details
    • 10.15.2 GE Healthcare Business Overview and Its Total Revenue
    • 10.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Introduction
    • 10.15.4 GE Healthcare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.15.5 GE Healthcare Recent Development
  • 13.16 Endocare
    • 10.16.1 Endocare Company Details
    • 10.16.2 Endocare Business Overview and Its Total Revenue
    • 10.16.3 Endocare Prostate-specific Antigen (PSA) Testing Introduction
    • 10.16.4 Endocare Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.16.5 Endocare Recent Development
  • 13.17 Merck&Co.
    • 10.17.1 Merck&Co. Company Details
    • 10.17.2 Merck&Co. Business Overview and Its Total Revenue
    • 10.17.3 Merck&Co. Prostate-specific Antigen (PSA) Testing Introduction
    • 10.17.4 Merck&Co. Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.17.5 Merck&Co. Recent Development
  • 13.18 Medtronic
    • 10.18.1 Medtronic Company Details
    • 10.18.2 Medtronic Business Overview and Its Total Revenue
    • 10.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Introduction
    • 10.18.4 Medtronic Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.18.5 Medtronic Recent Development
  • 13.19 Sanofi-Aventis SA
    • 10.19.1 Sanofi-Aventis SA Company Details
    • 10.19.2 Sanofi-Aventis SA Business Overview and Its Total Revenue
    • 10.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Introduction
    • 10.19.4 Sanofi-Aventis SA Revenue in Prostate-specific Antigen (PSA) Testing Business (2015-2020)
    • 10.19.5 Sanofi-Aventis SA Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Prostate-specific Antigen (PSA) Testing. Industry analysis & Market Report on COVID-19 Impact on Global Prostate-specific Antigen (PSA) Testing is a syndicated market report, published as COVID-19 Impact on Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Prostate-specific Antigen (PSA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,611.40
    5,417.10
    7,222.80
    590,265.00
    885,397.50
    1,180,530.00
    325,260.00
    487,890.00
    650,520.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report